Section Arrow
CGEM.NASDAQ
- Cullinan Therapeutics
Quotes are at least 15-min delayed:2025/06/01 08:12 EDT
Last
 8.63
-0.05 (-0.58%)
Day High 
8.85 
Prev. Close
8.68 
1-M High
8.97 
Volume 
594.56K 
Bid
7.91
Ask
13.3
Day Low
8.27 
Open
8.57 
1-M Low
6.86 
Market Cap 
512.25M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.83 
20-SMA 7.87 
50-SMA 7.92 
52-W High 24.76 
52-W Low 6.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.77/-3.00
Enterprise Value
513.10M
Balance Sheet
Book Value Per Share
9.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed:2025/06/01 08:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.